Joint statement on the current epidemics of new Coronavirus
Together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID we have worked on a joint statement to provide guidance in advising patients with primary immunodeficiency under our care in the current COVID-19 context.
The recently updated statement document can be accessed here.
We will soon ask for your collaboration in a survey on how SARS-CoV-2 affects PID patients.
Thanks to all who worked on this document,